Achillion Pharmaceuticals, Inc. (NQ:ACHN)
Delayed: 7.74 -0.01 (0.13%)
Trade Now!
Previous Close $7.75    52 Week High $11.36 
Open $7.78    52 Week Low $5.42 
Day High $7.95    P/E N/A 
Day Low $7.68    EPS $-0.64 
Volume 35,748       

Friends, Peers and Foes (?): GILD, IDIX, VRTX, ABT, BMY (more...)

May 15, 2013 06:00 AM Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
May 9, 2013 06:00 AM Achillion to Present at Three Upcoming Investor Conferences
May 7, 2013 04:10 PM Form 10-Q ACHILLION PHARMACEUTICAL For: Mar 31
May 7, 2013 06:15 AM Achillion Pharmaceuticals, Inc. (ACHN) Posts Q1 Loss of 14c/Share
May 7, 2013 06:00 AM Achillion Reports First Quarter 2013 Financial Results
Apr 23, 2013 06:03 AM Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress
Apr 23, 2013 06:00 AM Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients
Apr 16, 2013 06:37 AM Achillion (ACHN) Commences ACH-3102 Phase 2
Apr 16, 2013 06:30 AM Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV
Feb 22, 2013 06:41 AM Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40
View All Articles

Entities mentioned with ACHN

View All Entities